Medical Devices Investors & VC Firms in North America

1074 firms in this list, with a median first check of $500K. 236 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
RO Robo Global LCBCRSSM13 people · Leads rounds	88🔒	New York	US	Seed–Series B	$500K – $2M	+ Add to CRM
DR Draper Triangle JKMSTJZM6 people · Leads rounds	88🔒	Pittsburgh	US	Seed–Series A	$250K – $2M	+ Add to CRM
IN Inflect Health ASDFND3 people · Follows rounds	88🔒	San Francisco	US	Pre-Seed–Series A	$150K – $500K	+ Add to CRM
OL Old Line Capital Partners ALBDCPCB12 people	88🔒	Bowie	US	Pre-Seed–Seed	—	+ Add to CRM
AC ACADEMY INVESTOR EMFUTCSW5 people	88🔒	New York	US	Pre-Seed–Series A	—	+ Add to CRM
LA Launch Tennessee LCLI2 people	88🔒	Nashville	US	Pre-Seed–Series B	—	+ Add to CRM
DC DC Investment Partners DDJA10 people	88🔒	McLean	US	Seed–Growth	$10M	+ Add to CRM
GE Genesis Innovation Group CLMHRBUG13 people	88🔒	Grand Rapids	US	Seed–Series A	—	+ Add to CRM
LE Leva Capital MGAHBNCM15 people	88🔒	Toronto	CA	Pre-Seed–Series A	—	+ Add to CRM
EI Eisai Innovation, Inc. YMR(PWRC4 people	88🔒	Cambridge	US	Seed–Series A	$5M	+ Add to CRM
HM HM Venture Partners RLDHHHPL7 people · Leads rounds	88🔒	San Francisco	US	Seed–Growth	—	+ Add to CRM
AT ATEM Capital Fund AGDKEMIY12 people	88🔒	New York	US	Series A–Growth	—	+ Add to CRM
IN Innovation Cluster - Peterborough and the Kawarthas ACAMCBCC15 people	88🔒	Peterborough	CA	Pre-Seed–Seed	—	+ Add to CRM
AZ AZ Crown Investments DFECJWTC11 people	88🔒	Tempe	US	Seed–Series A	—	+ Add to CRM
AR Artiman Ventures ASASBWRR10 people	88🔒	Palo Alto	US	Seed–Late Stage	$2M – $6M	+ Add to CRM
AS Aspira Capital BLBGEKQA6 people	88🔒	Fort Lee	US	Seed–Series A	—	+ Add to CRM
B- B-FLEXION APNLSAFW12 people	88🔒	St. Helier	US	Growth	$500K	+ Add to CRM
GL Global Health Investment Corporation LMCPDSJP6 people	88🔒	New York	US	Seed–Series B	—	+ Add to CRM
TE Texas Ventures AVHMRGES6 people	88🔒	Houston	US	Seed–Late Stage	—	+ Add to CRM
SW Swan Venture Fund BBMMPWJR5 people · Leads rounds	88🔒	Seattle	US	Pre-Seed–Seed	$200K – $1.2M	+ Add to CRM
DI Diamond Edge Ventures CSNAHSKS10 people	88🔒	San Francisco	US	Seed–Series A	—	+ Add to CRM
LU Lucas Venture Group JBSLCCLW7 people	88🔒	Palo Alto	US	Seed–Series A	$1M – $5M	+ Add to CRM
CO Corner Ventures JPMTDKAC15 people	88🔒	New York	US	Seed–Late Stage	—	+ Add to CRM
GR GreyMatter ABDMALAW5 people · Follows rounds	88🔒	Berkeley	US	—	—	+ Add to CRM

Robo Global

New YorkSeed–Series B$500K – $2M

LCBCRSSM13 people

Draper Triangle

PittsburghSeed–Series A$250K – $2M

JKMSTJZM6 people

Inflect Health

San FranciscoPre-Seed–Series A$150K – $500K

ASDFND3 people

Old Line Capital Partners

BowiePre-Seed–Seed

ALBDCPCB12 people

ACADEMY INVESTOR

New YorkPre-Seed–Series A

EMFUTCSW5 people

Launch Tennessee

NashvillePre-Seed–Series B

LCLI2 people

DC Investment Partners

McLeanSeed–Growth$10M

DDJA10 people

Genesis Innovation Group

Grand RapidsSeed–Series A

CLMHRBUG13 people

Leva Capital

TorontoPre-Seed–Series A

MGAHBNCM15 people

Eisai Innovation, Inc.

CambridgeSeed–Series A$5M

YMR(PWRC4 people

HM Venture Partners

San FranciscoSeed–Growth

RLDHHHPL7 people

ATEM Capital Fund

New YorkSeries A–Growth

AGDKEMIY12 people

Innovation Cluster - Peterborough and the Kawarthas

PeterboroughPre-Seed–Seed

ACAMCBCC15 people

AZ Crown Investments

TempeSeed–Series A

DFECJWTC11 people

Artiman Ventures

Palo AltoSeed–Late Stage$2M – $6M

ASASBWRR10 people

Aspira Capital

Fort LeeSeed–Series A

BLBGEKQA6 people

B-FLEXION

St. HelierGrowth$500K

APNLSAFW12 people

Global Health Investment Corporation

New YorkSeed–Series B

LMCPDSJP6 people

Texas Ventures

HoustonSeed–Late Stage

AVHMRGES6 people

Swan Venture Fund

SeattlePre-Seed–Seed$200K – $1.2M

BBMMPWJR5 people

Diamond Edge Ventures

San FranciscoSeed–Series A

CSNAHSKS10 people

Lucas Venture Group

Palo AltoSeed–Series A$1M – $5M

JBSLCCLW7 people

Corner Ventures

New YorkSeed–Late Stage

JPMTDKAC15 people

GreyMatter

Berkeley

ABDMALAW5 people

Data sourced from public filings and firms' own websites — see our methodology.